SVA has an outstanding experience in the coordination and management of European and Innovative Medicine Initiative (IMI)-funded projects. Currently, the Association is:

• The Coordinator of the FP7 EU High Impact Project ADITEC on “Advanced Immunization Technologies” involving 42 Institutions from 12 EU countries and USA

• The Managing Entity Coordinator of the IMI Project FLUCOP “Standardisation and development of assays for assessment of influenza vaccine correlates of protection”

• The Coordinator of the IMI2 Project VSV-EBOVAC “Vaccine safety and immunogenicity signatures of human responses to VSV-ZEBOV”

• The Coordinator of the IMI2 Project VSV-EBOPLUS “Systems analysis of adult and pediatric responses to the VSV-ZEBOV Ebola vaccine”